Skip to content
Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion episode artwork

EPISODE · Aug 29, 2022 · 11 MIN

Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion

from PeerVoice Clinical Pharmacology Video · host PeerVoice

Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion

Episode metadata supplied by the publisher feed · Published Aug 29, 2022

Embed this episode

Visit https://www.peervoice.com/RHQ860 to view the entire programme with slides. After completing “Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion”, participants will be able to: Summarize the clinical evidence with the latest targeted therapies available for the treatment of relapsed/refractory acute myeloid leukemia (R/R AML); and Apply best practices to optimize the selection of targeted therapy in the treatment of R/R AML.

Distinct summary based on available episode metadata or transcript content.

Ready to play

Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion

0:00 11:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of PeerVoice Clinical Pharmacology Video?

This episode is 11 minutes long.

When was this PeerVoice Clinical Pharmacology Video episode published?

This episode was published on August 29, 2022.

Can I download this PeerVoice Clinical Pharmacology Video episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!